Skip to main content
. 2019 Jul 30;40(43):3516–3525. doi: 10.1093/eurheartj/ehz458

Figure 1.

Figure 1

Diagram of the study design. Patients with an outcome or censoring event before the start of follow-up at month m = 3 were excluded. ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.